id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-350103-liwvhuzj	Brooks, Nathan A.	The role of the urologist, BCG vaccine administration, and SARS‐CoV‐2: An overview	2020-06-22		.txt	text/plain	2850	144	39	OBJECTIVES: To summarize the available literature regarding bacillus Calmette‐Guerin (BCG) administration, severe acute respiratory syndrome conoravirus‐2 (SARS‐CoV‐2), and the resulting clinical condition coronavirus disease (COVID‐19) in light of recent epidemiologic work suggesting decreased infection severity in BCG immunized populations while highlighting the potential role of the urologist in clinical trials and ongoing research efforts. Specifically, the epidemiologic evidence for decreased COVID‐19 morbidity in countries with BCG vaccination programs, current clinical trials for BCG vaccination to protect against COVID‐19, potential mechanisms and rationale for this protection, and the role of the urologist and urology clinic in providing support and/or leading ongoing efforts. 18 In both animal and human studies, BCG vaccination provides a non-specific benefit to the immune system, relative protection against, and reduced mortality from infections by other microbes (bacteria and viruses) which may occur by epigenetic reprogramming and induction of trained immunity.	./cache/cord-350103-liwvhuzj.txt	./txt/cord-350103-liwvhuzj.txt